286 related articles for article (PubMed ID: 26851611)
21. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study.
Lora-Tamayo J; Parra-Ruiz J; Rodríguez-Pardo D; Barberán J; Ribera A; Tornero E; Pigrau C; Mensa J; Ariza J; Soriano A
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):66-71. PubMed ID: 24996840
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.
Niska JA; Shahbazian JH; Ramos RI; Pribaz JR; Billi F; Francis KP; Miller LS
Antimicrob Agents Chemother; 2012 May; 56(5):2590-7. PubMed ID: 22371896
[TBL] [Abstract][Full Text] [Related]
23. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
24. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus.
Fujimura S; Sato T; Kikuchi T; Zaini J; Gomi K; Watanabe A
J Orthop Sci; 2009 Sep; 14(5):658-61. PubMed ID: 19802681
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
Channabasappa S; Chikkamadaiah R; Durgaiah M; Kumar S; Ramesh K; Sreekanthan A; Sriram B
J Antimicrob Chemother; 2018 Dec; 73(12):3398-3404. PubMed ID: 30215762
[TBL] [Abstract][Full Text] [Related]
27. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Edmiston CE; Goheen MP; Seabrook GR; Johnson CP; Lewis BD; Brown KR; Towne JB
Am J Surg; 2006 Sep; 192(3):344-54. PubMed ID: 16920429
[TBL] [Abstract][Full Text] [Related]
28. In vivo verification of in vitro model of antibiotic treatment of device-related infection.
Blaser J; Vergères P; Widmer AF; Zimmerli W
Antimicrob Agents Chemother; 1995 May; 39(5):1134-9. PubMed ID: 7625801
[TBL] [Abstract][Full Text] [Related]
29. First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin.
Tsukimori A; Nakamura I; Okamura S; Sato A; Fukushima S; Mizuno Y; Yamaguchi T; Matsumoto T
BMC Infect Dis; 2014 Aug; 14():459. PubMed ID: 25149872
[TBL] [Abstract][Full Text] [Related]
30. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
31. Prevention and treatment of Staphylococcus aureus biofilms.
Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
Salem AH; Elkhatib WF; Noreddin AM
J Pharm Pharmacol; 2011 Jan; 63(1):73-9. PubMed ID: 21155818
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
Appleman MD; Citron DM
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
[TBL] [Abstract][Full Text] [Related]
35. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
[TBL] [Abstract][Full Text] [Related]
36. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
37. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
Kebriaei R; Lehman SM; Shah RM; Stamper KC; Kunz Coyne AJ; Holger D; El Ghali A; Rybak MJ
Microbiol Spectr; 2023 Jun; 11(3):e0491822. PubMed ID: 37199616
[TBL] [Abstract][Full Text] [Related]
38. Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.
Boudjemaa R; Steenkeste K; Jacqueline C; Briandet R; Caillon J; Boutoille D; Le Mabecque V; Tattevin P; Fontaine-Aupart MP; Revest M
J Antimicrob Chemother; 2018 Sep; 73(9):2418-2421. PubMed ID: 29901764
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
40. A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.
Chan C; Hardin TC; Smart JI
Future Microbiol; 2015; 10(8):1325-38. PubMed ID: 26083676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
